Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy: A Cross-Sectional Study from Tororo, Uganda

• Emmanuel Arinaitwe,

  Affiliation Infectious Disease Research Collaboration, Kampala, Uganda

  ⨯
• Veronica Ades,

  Affiliation Department of Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Andrew Walakira,

  Affiliation Infectious Disease Research Collaboration, Kampala, Uganda

  ⨯
• Boaz Ninsiima,

  Affiliation Infectious Disease Research Collaboration, Kampala, Uganda

  ⨯
• Olive Mugagga,

  Affiliation Infectious Disease Research Collaboration, Kampala, Uganda

  ⨯
• Teja S. Patil,

  Affiliation Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Alanna Schwartz,

  Affiliation Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Moses R. Kamya,

  Affiliation Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda

  ⨯
• Sussann Nasr,

  Affiliation Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Michelle Chang,

  Affiliation Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Scott Filler,

  Affiliation The Global Fund to Fight Acquired Immune Deficiency Syndrome, Tuberculosis, and Malaria, Geneva, Switzerland

  ⨯
• Grant Dorsey

  * E-mail: gdorsey@medsfgh.ucsf.edu

  Affiliation Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯